Privia Health Group (NASDAQ:PRVA) Sets New 52-Week High - Here's Why

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) hit a new 52-week high during trading on Thursday . The company traded as high as $25.80 and last traded at $25.67, with a volume of 211418 shares changing hands. The stock had previously closed at $24.06.

Analyst Upgrades and Downgrades

PRVA has been the topic of several recent research reports. Needham & Company LLC increased their price objective on Privia Health Group from $25.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective for the company. Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Stephens reiterated an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. boosted their price target on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Friday, November 29th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $26.47.

Privia Health Group Stock Down 0.0 %

The company has a 50 day simple moving average of $22.40 and a 200 day simple moving average of $20.61. The stock has a market cap of $3.00 billion, a price-to-earnings ratio of 249.62, a P/E/G ratio of 3.47 and a beta of 0.87.

Remove Ads

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PRVA. Mackenzie Financial Corp boosted its holdings in shares of Privia Health Group by 87.2% during the 4th quarter. Mackenzie Financial Corp now owns 72,391 shares of the company's stock valued at $1,415,000 after acquiring an additional 33,728 shares in the last quarter. Neo Ivy Capital Management raised its position in Privia Health Group by 81.5% in the fourth quarter. Neo Ivy Capital Management now owns 6,540 shares of the company's stock valued at $127,000 after purchasing an additional 2,936 shares during the last quarter. PharVision Advisers LLC acquired a new stake in shares of Privia Health Group during the fourth quarter valued at about $259,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Privia Health Group by 13.9% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 939,170 shares of the company's stock worth $18,361,000 after purchasing an additional 114,647 shares during the last quarter. Finally, Two Sigma Advisers LP acquired a new position in shares of Privia Health Group in the fourth quarter valued at approximately $940,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.